ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 268 out of 783

$595K Total Retail Price of All Prescriptions

Rank: 202 out of 783

484 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,427 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 346 333 1 1
SIMVASTATIN 338 335 2 3
LISINOPRIL 279 259 3 4
AMLODIPINE BESYLATE 211 194 4 5
ATORVASTATIN CALCIUM 211 204 4 11
FUROSEMIDE 208 194 6 7
METOPROLOL SUCCINATE 197 191 7 13
HYDROCODONE-ACETAMINOPHEN 192 177 S3 8 2
METFORMIN HCL 188 166 9 8
ZOLPIDEM TARTRATE 171 156 10 23
LOSARTAN POTASSIUM 142 142 11 18
OMEPRAZOLE 140 127 12 6
AZITHROMYCIN 135 126 13 41
TRIAMTERENE-HCTZ 116 112 14 42
TAMSULOSIN HCL 111 108 15 26
CRESTOR 102 96 16 27
DIOVAN 98 95 17 49
SERTRALINE HCL 97 95 18 22
WARFARIN SODIUM 96 96 19 10
PRAVASTATIN SODIUM 92 89 20 14
CARVEDILOL 91 79 21 21
ATENOLOL 89 83 22 17
GLIPIZIDE ER 85 72 23 84
SYNTHROID 80 77 24 47
ENALAPRIL MALEATE 80 77 24 68
TRAZODONE HCL 74 71 26 39
CYMBALTA 72 68 27 35
NEXIUM 72 68 27 28
JANUVIA 66 66 29 73
ALLOPURINOL 65 60 30 31
FLUTICASONE PROPIONATE 64 62 31 46
EVISTA 64 61 31 92
POTASSIUM CHLORIDE 60 60 33 16
METOPROLOL TARTRATE 59 59 34 9
LOSARTAN-HYDROCHLOROTHIAZIDE 55 41 35 53
CIPROFLOXACIN HCL 55 54 35 62
GABAPENTIN 54 49 37 15
MECLIZINE HCL 53 47 38 146
FLUOXETINE HCL 52 52 39 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.